Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Palmer Natural Products is recalling unapproved Piracetam and Choline capsules marketed without FDA approval.
Hospira is recalling 624,240 units of 0.9% Sodium Chloride Injection, USP, 50 mL, due to a lack of assurance of sterility and potential leakage.
Palmer Natural Products is recalling 250 bottles of Aniracetam and Choline capsules because they were marketed without an approved NDA or ANDA.
Palmer Natural Products is recalling 723 bottles of unapproved Piracetam and Choline capsules sold online and in four states.
Teva Pharmaceuticals is recalling specific lots of Clonazepam orally disintegrating tablets because they failed content uniformity specifications.
Palmer Natural Products is recalling Oxiracetam & Choline capsules because they were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Palmer Natural Products is recalling Aniracetam & Choline capsules because they were marketed without an approved NDA or ANDA.
Palmer Natural Products is recalling Brain Defogger capsules because they were marketed without FDA approval. The product was sold in Florida, Idaho, California, and Hong Kong.
Ferring Pharmaceuticals is recalling 126 injectors of TEV-TROPIN because the cartons are labeled for Needle-Free Head B but contain Needle-Free Head A.
Fougera Pharmaceuticals is voluntarily recalling 60,210 units of Ketoconazole Cream 2% because an unknown degradant failed impurity specifications.
Dr. Reddy's Laboratories is recalling Tizanidine Tablets because bottle labels may be missing the product strength and other printing details.
Hospira Inc. is recalling 68,020 vials of Propofol Injectable Emulsion, 1%, due to the presence of visible particulate matter.
CareFusion 213, LLC is recalling 544,500 FREPP/SEPP kits because the product is not sterile, but the labeling misleadingly implies it is.
Zydus Pharmaceuticals USA Inc. is recalling 13,320 bottles of Venlafaxine Hydrochloride 75 mg tablets due to a complaint of excessive broken or chipped tablets.
CareFusion 213, LLC is recalling 698,000 SEPP 70% Isopropanol applicators because the product is not sterile, making the labeling misleading regarding sterility claims.
Hill Dermaceuticals is recalling 8,592 bottles of Derma-Smoothe/FS topical oil because the product was found to be subpotent at a 22-month stability timepoint.
Physicians Total Care is recalling Tetracycline 500 mg capsules due to a potential for foreign particulate matter in the active pharmaceutical ingredient.
West-ward Pharmaceutical Corp. is recalling Ciprofloxacin 500 mg tablets due to a complaint of rubber-like material found in a tablet.
Physicians Total Care is recalling Tetracycline 250 mg capsules due to a potential for foreign particulate matter in the active pharmaceutical ingredient.
CareFusion is recalling SEPP 10% Povidone Iodine Solution applicators because the product is not sterile, making the sterility claims on the label misleading.
CareFusion 213, LLC is recalling SEPP 2% Iodine Tincture applicators because the product is not sterile, making the labeling misleading regarding sterility claims.
Hill Dermaceuticals is recalling 8,736 bottles of Derma-Smoothe/FS topical oil because the product was found to be subpotent at the 12-month stability timepoint.
Pfizer is recalling 10,920 TORISEL (temsirolimus) kits nationwide due to a lack of assurance of sterility and potential low-level endotoxins in the diluent vials.
Hospira is recalling 1,296 units of Lactated Ringer's Injection, USP, 1000 mL, because the product was shipped without approval for release.
L. Perrigo is recalling 60,048 blister packs of PE Daytime Cold/Flu LiqGel because the active ingredient Phenylephrine HCl was subpotent at the 12-month time point.